Stock-Based Compensation and Other Employee Benefit Plans (Tables)

3 Months Ended

Mar. 31, 2018



Activity, restricted shares: ^(a)	Restricted Shares		Per Share Weighted Average Grant Date Fair Value
Non-vested restricted shares, as of December 31, 2017	1,448,591		$	23.29
Granted	111,367		50.83
Vested	(2,372	)	50.60
Canceled/forfeited	(6,552	)	22.23
Non-vested restricted shares, as of March 31, 2018	1,551,034		$	25.23


(a)	Includes 27,550 restricted stock units as of both March 31, 2018 and December 31, 2017, respectively.

Schedule of Activity, Employee Stock Purchase Plans

The following table provides details pertaining to the Company’s ESPPs for the periods indicated:



	For the Three Months Ended March 31
	2018		2017
Cash proceeds (in millions)	$	1.0	$	0.8
Common shares issued	25,638		24,026
Weighted average price per share	$	39.99	$	32.51
Weighted average per share grant date fair value	$	9.79	$	8.49

Schedule of Non-Cash Stock-Based Compensation Expense and Related Tax Effects

Details of non-cash stock-based compensation expense and related tax effects for the periods indicated were as follows (in millions):



	For the Three Months Ended March 31
	2018		2017
Non-cash stock-based compensation expense	$	3.2	$	3.8
Income Tax Effects:
Income tax effect of non-cash stock-based compensation	$	0.8	$	1.2
Excess tax benefit from non-cash stock-based compensation ^(a)	$	—	$	—

(a)

Excess tax benefits represent cash flows from tax deductions in excess of the tax effect of compensation expense associated with share-based payment arrangements. For the three month period ended March 31, 2018, tax benefits, net of tax deficiencies, related to the vesting of share-based payment awards were de minimis, and, for the three month period ended March 31, 2017, the Company recognized a tax deficiency, net of tax benefits, of $0.2 million.